4//SEC Filing
Molecular Insight Pharmaceuticals, Inc. 4
Accession 0001209191-07-007511
CIK 0001340752operating
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 4:09 PM ET
Size
12.0 KB
Accession
0001209191-07-007511
Insider Transaction Report
Form 4
Babich John W
DirectorPresident, CEO and CSO
Transactions
- Conversion
Common Stock
2007-02-01+27,702→ 27,702 total - Conversion
Series A Convertible Preferred Stock
2007-02-01−641→ 0 total→ Common Stock (27,702 underlying)
Footnotes (4)
- [F1]The reporting person held 641 shares of Series A Convertible Preferred Stock. In connection with the issuer's IPO, the Series A Convertible Preferred Stock automatically converted into 27,702 shares of Common Stock, which number of shares includes accrued and unpaid dividends on the Series A Preferred Stock as of February 1, 2007.
- [F2]Immediately.
- [F3]Not applicable.
- [F4]The reporting person holds Employee Stock Options to purchase 594,167 shares of the Common Stock, as previously reported on Form 3.
Issuer
Molecular Insight Pharmaceuticals, Inc.
CIK 0001340752
Entity typeoperating
IncorporatedMA
Related Parties
1- filerCIK 0001340752
Filing Metadata
- Form type
- 4
- Filed
- Feb 4, 7:00 PM ET
- Accepted
- Feb 5, 4:09 PM ET
- Size
- 12.0 KB